NCT07219043View on ClinicalTrials.gov

A Study to Learn About the Effects of Felzartamab Infusions on Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

November 17, 2025

Primary Completion Date

February 10, 2028

Study Completion Date

February 10, 2028

Conditions
Microvascular Inflammation
Interventions
DRUG

Felzartamab

Administered IV

DRUG

Placebo

Administered IV

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT07219043 - A Study to Learn About the Effects of Felzartamab Infusions on Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation | Biotech Hunter | Biotech Hunter